AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.1563
-0.0047 (-2.92%)
Oct 23, 2026, 4:00 PM EDT - Market closed
AIM ImmunoTech Market Cap
AIM ImmunoTech has a market cap or net worth of $4.76 million as of October 23, 2026. It is the 45,081st most valuable company in the world and the 6,028th biggest in the United States. Its market cap has decreased by 33.28% in one year.
Market Cap
4.76M
Enterprise Value
-1.28M
1-Year Change
-33.28%
Global Rank
Country Rank
#6,028 United States
Category
ChartMarket Cap Chart
Since July 12, 1996, AIM ImmunoTech's market cap has decreased from $40.85M to $4.76M, a decrease of -88.35%. That is a compound annual growth rate of -6.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 4.76M | 47.58% |
| Dec 31, 2025 | 3.22M | -74.47% |
| Dec 31, 2024 | 12.63M | -41.22% |
| Dec 29, 2023 | 21.49M | 43.27% |
| Dec 30, 2022 | 15.00M | -65.93% |
| Dec 31, 2021 | 44.02M | -39.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evogene | 5.94M |
| Processa Pharmaceuticals | 5.90M |
| Niki BioSolutions | 5.88M |
| Traws Pharma | 5.79M |
| Pulmatrix | 5.73M |
| Cardio Diagnostics Holdings | 5.24M |
| Creative Medical Technology Holdings | 4.89M |
| Xenetic Biosciences | 4.73M |